SCHEMBL14367441

SCHEMBL14367441

Cc1nn(C)cc1CN(C)C(=O)c1cc2nc(-c3ccccc3)cc(C(F)(F)F)n2n1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.76
ALDH1A1 P00352 9/20 0.76
HSD17B10 Q99714 5/20 0.76
KMT2A Q03164 4/20 0.76
CASP1 P29466 3/20 0.76
MEN1 O00255 3/20 0.76
PKM P14618 1/20 0.76
CASP7 P55210 1/20 0.76
NPSR1 Q6W5P4 3/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
SMN1; SMN2 Q16637 5/20 0.57
TSHR P16473 1/20 0.55
HPGD P15428 5/20 0.54
TP53 P04637 3/20 0.54
LMNA P02545 3/20 0.54
PRNP P04156 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
POLB P06746 1/20 0.52
MAPK1 P28482 1/20 0.50
THRB P10828 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14367444 0.91 ALDH1A1 (0.71) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL14367447 0.87 ALDH1A1 (0.73) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL1718188 0.85 ALDH1A1 (0.78) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL14535590 0.83 ALDH1A1 (0.62) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL1718290 0.82 ALDH1A1 (0.76) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL16615203 0.81 KDM4E (0.67) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL14367451 0.78 ALDH1A1 (0.56) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL3278525 0.77 KDM4E (1.00) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL1720214 0.77 KDM4E (0.72) KDM4EALDH1A1HSD17B10KMT2ACASP1
SCHEMBL14367630 0.76 KDM4E (0.61) KDM4EALDH1A1HSD17B10KMT2ACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
EP-1782859-A2 Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines NOVO NORDISK A/S (DK) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines HSD3B1, HSD11B1, SRD5A1 KDM4E 3872/4885ALDH1A1 133/4885HSD17B10 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.